![Ben Woolven](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ben Woolven
Consultant / Advisor chez
Resolution Therapeutics Ltd.
Profil
Ben joined Syncona from GlaxoSmithKline where he has over a decade of strategy development, business operations and project management experience.
Latterly Ben worked with GlaxoSmithKline’s Chief Medical Officer, where he led reconfiguration of global and regional medical functions in anticipation of their evolving pharma portfolio.
Prior to this, Ben held various strategy and operations roles building scientific teams, developing justifications for new scientific investments, leading project management offices and providing R&D consultancy support, including a secondment to L.E.K Consulting.
Prior to joining GlaxoSmithKline Ben played a key role in the success of Domantis, an antibody fragment start-up, sold to GlaxoSmithKline for £230 million.
Ben holds a PhD in Immunology.
Postes actifs de Ben Woolven
| Sociétés | Poste | Début |
|---|---|---|
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in biotechnology | Consultant / Advisor | 01/02/2022 |
Anciens postes connus de Ben Woolven
| Sociétés | Poste | Fin |
|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Private Equity Investor | 01/11/2022 |
| GSK PLC | Directeur/Membre du Conseil | 01/02/2022 |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Corporate Officer/Principal | 01/02/2009 |
Formation de Ben Woolven
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Domantis Ltd.
Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kent
 University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Resolution Therapeutics Ltd.
Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in biotechnology | Commercial Services |
Choisissez Zonebourse 
